Sign in to view content

Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME

Seenu M. Hariprasad, MD

Video
Published 2018

Related

Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes
Jeffrey G. Gross, MD, FASRS
Annual Meeting Talks
2018
Evolving Trends in Practice Patterns of North American Vitreoretinal Surgery Fellows From 2010-2016
Robert Gizicki, MD, FRCSC, DABO
Annual Meeting Talks
2018
Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results
Sam E. Mansour, MD, MSc,FACS, FRCS(C)
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more